Skip to main content
Microbial Genomics logoLink to Microbial Genomics
. 2023 Dec 6;9(12):001148. doi: 10.1099/mgen.0.001148

Distribution and diversity of type VI secretion system clusters in Enterobacter bugandensis and Enterobacter cloacae

Amy J G Anderson 1, Becca Morrell 1, Guillermo Lopez Campos 1, Miguel A Valvano 1,*
PMCID: PMC10763514  PMID: 38054968

Abstract

Gram-negative bacteria use type VI secretion systems (T6SSs) to antagonize neighbouring cells. Although primarily involved in bacterial competition, the T6SS is also implicated in pathogenesis, biofilm formation and ion scavenging. Enterobacter species belong to the ESKAPE pathogens, and while their antibiotic resistance has been well studied, less is known about their pathogenesis. Here, we investigated the distribution and diversity of T6SS components in isolates of two clinically relevant Enterobacter species, E. cloacae and E. bugandensis . T6SS clusters are grouped into four types (T6SSi-T6SSiv), of which type i can be further divided into six subtypes (i1, i2, i3, i4a, i4b, i5). Analysis of a curated dataset of 31 strains demonstrated that most of them encode T6SS clusters belonging to the T6SSi type. All T6SS-positive strains possessed a conserved i3 cluster, and many harboured one or two additional i2 clusters. These clusters were less conserved, and some strains displayed evidence of deletion. We focused on a pathogenic E. bugandensis clinical isolate for comprehensive in silico effector prediction, with comparative analyses across the 31 isolates. Several new effector candidates were identified, including an evolved VgrG with a metallopeptidase domain and a Tse6-like protein. Additional effectors included an anti-eukaryotic catalase (KatN), M23 peptidase, PAAR and VgrG proteins. Our findings highlight the diversity of Enterobacter T6SSs and reveal new putative effectors that may be important for the interaction of these species with neighbouring cells and their environment.

Keywords: comparative genomics, T6SS effectors, T6SS gene cluster, T6SS gene organization, T6SS subtype

Data Summary

The complete genome sequences of E. bugandensis isolates E104107 and E105227 are available under NCBI accession numbers NZ_CP110983.1 and NZ_CP110985.1, respectively. The code used is described in Table S1 (available in the online version of this article), while strain accession numbers and metadata are shown in Table S6. All authors confirm support of data, codes and protocols noted within the article.

Impact Statement.

The genus Enterobacter includes multiple species of Gram-negative bacteria from the family Enterobacteriaceae , which are commonly found in the human gut microbiota and can become opportunistic pathogens resulting in bacteraemia, intra-abdominal infections and infections in multiple body sites. A major concern with Enterobacter infections is the frequent appearance of multidrug-resistant isolates, for which these bacteria are included in the ESKAPE list of global-threat pathogens requiring last-resort antibiotics. Many Gram-negative bacteria utilize type VI secretion systems (T6SSs) for bacterial-competition and virulence. Understanding how the Enterobacter T6SS can be used to manipulate bacteria and eukaryotic cells may provide insights into the pathogenesis of this genus.

Introduction

Bacteria often live in complex polymicrobial communities where they compete for nutrients and space [1–3]. Many bacteria have evolved strategies to outcompete their neighbours and dominate their environmental niche [4–6]. One such strategy involves the type VI secretion system (T6SS), a bacterial nanomachine that deploys a range of antibacterial effectors [7–9]. The current model of T6SS assembly comprises 13 core components that are required for secretion. The membrane complex (TssJLM) anchors the T6SS to the bacterial membrane and allows docking of a baseplate complex (TssEGFK) encompassing a VgrG-PAAR spike [10, 11]. The Hcp tube is assembled onto a VgrG trimer and is surrounded by a contractile TssBC sheath in extended conformation [12, 13]. Assembly is coordinated by TssA and the sheath contracts to propel the Hcp-VgrG-PAAR puncturing device across the membrane of adjacent target cells [14–16]. Finally, the sheath is disassembled by TssH, an AAA+ ATPase, in preparation for re-firing.

The puncturing device is decorated with a payload of toxic effectors that perform several functions. Effectors are broadly grouped into two categories: evolved effectors and cargo effectors. Evolved effectors are covalently fused, typically as C-terminal extensions, to any of the VgrG, Hcp or PAAR structural components, while cargo effectors are non-covalently attached to any one of the VgrG, Hcp or PAAR components and may also require chaperones for loading or stability [17–20]. Immunity proteins protect attacking cells from self-intoxication by binding and neutralizing own effectors before loading onto the T6SS [21, 22]. These proteins are often encoded by genes adjacent to their corresponding effector genes. T6SS genes encoding structural components, effectors, immunity proteins, regulators and other accessory proteins are normally arranged in clusters; bacteria may have multiple T6SS clusters within their genomes [23–27]. However, not all effectors are encoded within clusters and their genes may be scattered across the genome. Bacteria can display significant diversity in their T6SS genomic organization, with components distributed in clusters, in lone genes or with T6SS-associated genes, such as hcp, PAAR and vgrG, to form auxiliary modules [28–30]. Although primarily utilized for bacterial competition, the T6SS is a versatile system that can also function in pathogenesis, biofilm formation, anti-fungal activity, self-recognition and ion scavenging [31–35].

The T6SS is widely distributed among Gram-negative bacteria, including many pathogenic species [27, 36–39]. Members of the ESKAPE pathogens utilize the T6SS for a range of activities including inter-bacterial competition and host cell invasion [27, 38, 40–44]. Enterobacter species are represented in the last ‘E’ of the ESKAPE pathogens, but the taxonomy of Enterobacter species is complicated [45, 46]. Currently, there are 56 species within the genus Enterobacter , 22 of which are published with accepted names [List of Prokaryotic Names with Standing in Nomenclature (accessed: 7 June 2023); https://lpsn.dsmz.de/genus/Enterobacter] [47]. Although not all species are pathogenic, some have emerged as important nosocomial pathogens and are generally referred to as the Enterobacter cloacae complex [48–51]. The Enterobacter T6SS has been investigated in E. cloacae type strain ATCC 13047, which possesses two T6SS clusters (termed T6SS-1 and T6SS-2) utilized for gut colonization, bacterial competition, biofilm formation and epithelial cell adherence [40]. Only four effectors involved in bacterial competition have been characterized to date in E. cloacae ; these include Tae4, an anti-bacterial peptidoglycan-targeting effector with amidase activity [41], two anti-bacterial rearrangement hotspot (Rhs) proteins, RhsA and RhsB [52], and a Tle phospholipase [52].

This study aimed to further elucidate the distribution and diversity of T6SSs within Enterobacter bugandensis in comparison with E. cloacae . Both species were chosen due to their relevance in clinical settings. E. bugandensis was first identified and characterized in 2016 from a nosocomial sepsis outbreak [53]. It is highly multi-drug resistant and believed to be the most virulent species within the genus Enterobacter [54, 55]. E. cloacae is currently the most frequently isolated Enterobacter species in healthcare settings [56, 57]. Here, we characterized the T6SS clusters in a curated set of 31 E. bugandensis and E. cloacae strains. We also focused on the pathogenic clinical isolate, E. bugandensis E104107, to extensively characterize, in silico, effectors and other components within T6SS clusters. Comparative analysis of the discussed effectors was performed across all strains in this study.

Methods

Analytical workflow

The workflow analysis we employed for T6SS cluster extraction, classification, visualization and effector prediction is depicted in Fig. 1.

Fig. 1.

Fig. 1.

Workflow overview of T6SS analysis in E. bugandensis and E. cloacae strains. Thirty-one E. bugandensis and E. cloacae genomes were obtained from NCBI, and the correct taxonomy was confirmed using the Type (Strain) genome server. T6SS clusters were predicted based on their presence of six or more core components. TssB protein sequences from clusters were extracted and submitted to the SecReT6 classification tool for subtype classification. Cblaster was used to plot and visualize clusters across the 31 strains based on cluster subtype. An E. bugandensis clinical isolate, E. bugandensis E104107, was chosen as a model strain for in-depth T6SS cluster analysis and effector prediction using a range of automated and manual prediction tools. Comparative analysis of identified effector candidates was carried out across the 31 strains included in this study.

Construction of genome libraries

The nucleotide and protein FASTA sequences, and gff3 annotation files for all complete E. cloacae and E. bugandensis genomes were obtained from the RefSeq NCBI database (18 November 2022) and from GenBank for those not available in the RefSeq database. The correct taxonomy of all 90 extracted genomes was assigned using the Type (Strain) Genome Server (TYGS) [58]. The DNA FASTA query files for all 90 genomes were submitted to TYGS and taxonomy identification was performed using default settings. Incorrectly assigned genomes were removed, leaving us with a curated dataset of 31 E. bugandensis and E. cloacae genomes.

Identification, classification and visualization of T6SS clusters

The SecReT6 v3.0 web server was used to identify T6SS components using the chromosome and plasmid FASTA nucleotide files of our curated dataset [59]. The minimum number of T6SS cluster components was set to 6 [29, 60], and all other search parameters were set to default. Plasmids were excluded from further analysis. Extracted TssB protein sequences were compiled and submitted to the SecReT6 v3.0 T6SS classification web server; phylogenetic analysis was performed using MAFFT v7.475 and FastTree v2.1.11 [59]. Cluster subtypes were noted, and the phylogenetic tree file was extracted and submitted to iTOL v6 for annotation and visualization [61].

Cblaster was used to plot and visualize clusters [62]. Local sqlite3, diamond and FASTA genome databases were constructed by cblaster based on cluster subtypes using the FASTA nucleotide and annotation (.gff3) files of the 31 genomes. A local search was performed using the diamond databases and FASTA files containing three conserved protein sequences as queries (Table S2), which included one upstream and downstream flanking gene and a conserved sequence within the cluster. Some clusters demonstrated a conserved upstream flanking region and variable downstream regions. For the clusters with variable downstream regions, one upstream flanking gene and two conserved sequences within the cluster were used. The maximum distance between the start/end of a cluster and an intermediate gene was set to 30 000 bp, the maximum distance between any two hits in a cluster was set to 50 000 bp and intermediate genes were included. The FASTA output file and JSON session file were obtained, and the JSON session file was used to extract the cluster sequences in GenBank (gbk) format. The JSON session file was also used to plot clusters and visualize them in clinker [63], which is also part of cblaster. Clusters were scored and arranged by cblaster based on similarity [62]. Cluster similarity was calculated by S=h+i.s, where h is the number of query sequences with blast hits, s is the number of contiguous gene pairs with conserved synteny and i is a weighting factor (default value 0.5) determining the weight of synteny in the similarity score [62].

In silico prediction of T6SS components and effectors

The E. bugandensis E104107 genome sequence was used as a template for in-depth in silico T6SS analysis and effector prediction. Automated prediction of T6SS components and effectors was performed with SecReT6 v3.0 and Bastion6 web tools, respectively [59, 64]. Genes within and surrounding predicted T6SS clusters, and predicted effectors across the whole genome, were manually analysed by structural (HHpred, Phyre2, DALI server) and sequence similarity [blast, NCBI conserved domain search (CDS)] tools [65–69]. Transmembrane regions and signal peptides were predicted with DeepTMHMM (https://dtu.biolib.com/DeepTMHMM) and SignalP 6.0, respectively [70]. SecretomeP 2.0 was used to predict non-classically secreted proteins [71]. To identify auxiliary modules, a cblaster local FASTA database was created and used to perform HMMER searches using Hcp (PF05638), PAAR (PF05488, PF13665) and VgrG (PF13296, PF04717) Pfam IDs (obtained on 1 March 2023; available at: https://www.ebi.ac.uk/interpro/entry/pfam/#table). PAAR, VgrG and Hcp protein sequences were extracted and NCBI CDS was used to verify correct domain identification. For comparative effector analysis, BLASTp was employed with default parameters to search a local protein FASTA database of the 31 genomes for effectors discussed in this study [68]. ColabFold (combining AlphaFold2 and MMseqs2) was used to predict effector structures from their amino acid sequences, which were visualized with PyMOL v2.5 [72].

Results

Most E. bugandensis and E. cloacae genomes carry at least two T6SS clusters

We investigated the prevalence and distribution of T6SS clusters in complete genomes of E. bugandensis and E. cloacae strains using the workflow described in Fig. 1. SecReT6 v3.0 was used to predict effectors encoded in all 31 genomes within our dataset (Table S7). Twelve E. bugandensis and 78 E. cloacae complete genome sequences were extracted from the NCBI assembly database. Prior to any analysis, we determined in silico the taxonomy of all 90 strains using TYGS. From these results, we excluded 59 genomes from our initial dataset since they corresponded to species incorrectly named ‘ E. cloacae ’; these included Enterobacter sichuanensis , E. hormaechei , E. asburiae , E. mori , E. kobei and E. roggenkampii . The remaining 31 genomes, ranging from 4 199 688 to 6 193 009 bp in size (with 3851–6208 proteins, and GC content ranging from 53.73% to 57.26 %), were used for further analysis (Fig. S1). The 31 genomes in our final dataset included 12 E. bugandensis and 19 E. cloacae strains. T6SS clusters in the 31-genome dataset were identified based on the presence of six or more core gene components, since clusters with fewer than six core components are unlikely to contain the tssB gene required for cluster classification (Table S3) [29, 60]. Most E. bugandensis and E. cloacae strains (93.5%) possessed at least one T6SS cluster (Fig. 2 and Table S4). E. bugandensis strains consistently carried two or three T6SS clusters, while E. cloacae strains displayed greater variability, ranging from zero (two strains) to three clusters. The plasmids of these strains were excluded from further analysis since they lacked T6SS components, in agreement with a previous study that identified T6SS clusters on only 1 % of 30 660 plasmids [29].

Fig. 2.

Fig. 2.

Number of T6SS clusters across E. bugandensis and E. cloacae strains. The percentage of E. cloacae strains possessing 0–3 T6SS clusters is shown in blue. The percentage of E. bugandensis strains possessing 0–3 T6SS clusters is shown in red.

All T6SS-positive strains carry a primary i3 cluster and a variable number of secondary i2 clusters

T6SSs can be classified into four types (i, ii, iii, iv), of which T6SSi is the most common type found in the Proteobacteria [60, 73–75]. T6SSi consists of six subtypes (i1, i2, i3, i4a, i4b, i5). The T6SS clusters identified in E. bugandensis and E. cloacae were classified according to the TssB amino acid sequence since this protein alone is adequate for T6SS cluster classification [60]. Clusters were grouped and displayed in subtypes based on experimentally validated TssB proteins from other species in the SecReT6 database (Fig. 3) [59, 60]. Seventy-seven TssB protein sequences were identified in the 31 genomes, 62 of which were present in clusters with ≥6 core structural gene components. The 15 TssB sequences that were not identified within clusters may correspond to remnant genes from degraded or non-functional clusters [29, 60]. The T6SS clusters identified in E. bugandensis and in E. cloacae belonged to either subtype i2 or i3 (Figs 2 and 3). Each T6SS-positive strain carried an i3 cluster, termed T6SSi3, which was referred to as the ‘primary’ cluster since it was highly conserved among strains.

Fig. 3.

Fig. 3.

Phylogenetic tree of E. cloacae and E. bugandensis T6SS cluster classification. A phylogenetic tree of all E. cloacae and E. bugandensis T6SS clusters identified in this study was reconstructed based on validated TssB protein sequences in the SecReT6 database. Phylogenetic analysis was performed using MAFFT v7.475 and FastTree v2.1.11 via the SecReT6 classification tool. Clusters are divided into four types (i, ii, iii, iv), and type i is further divided into six subtypes (i1, i2, i3, i4a, i4b, i5). All E. cloacae and E. bugandensis T6SSi3 clusters (highlighted in red) are grouped with validated type i3 TssB reference sequences. Similarly, all E. cloacae and E. bugandensis T6SSi2 clusters (highlighted in red) are grouped with validated type i2 TssB reference sequences.

T6SSi3 clusters were present in the same genomic location, with every cluster flanked by an upstream fdhF/ydeP family oxidoreductase gene. Additional genes in the upstream flanking region were also conserved based on visual inspection (Fig. S2), while downstream flanking genes displayed more variability between strains. All T6SSi3 clusters contained a highly conserved upstream structural region and a variable downstream ‘vgrG island’ encoding many unknown genes (Fig. S2). The upstream structural region encoded almost all structural genes and displayed the same gene organization between strains; this region encoded 12 out of 13 core protein components required for a functional T6SS (TssABCDEFGHJKLM) (Figs 4a and S2). TssI (also known as VgrG) proteins were encoded in the variable downstream region. There was no evidence of gene deletions or duplications, indicating low plasticity in the upstream structural region. The T6SSi3 structural region encoded only one conserved Tae4/Tai4 effector/immunity-protein pair [41]. The downstream region of T6SSi3 was variable in size and gene organization. Multiple putative effector genes were identified in this region, including genes encoding a Tse6-like protein, an evolved VgrG and RhsA/RhsB proteins. Moreover, T6SSi3 encoded predicted immunity proteins with no apparent corresponding effectors. For example, E. bugandensis E104107 encoded a Tri1 immunity protein while the gene encoding the corresponding effector, Tre1, was absent in the genome (Fig. 4a). Immunity proteins with no corresponding effectors may provide an advantage against other T6SS-weilding bacteria by increasing protection against their incoming repertoire of effectors, despite not using these effectors themselves. The variable downstream region also encoded several putative regulators, including TagF, TagH, Ser/Thr phosphatases and kinases. Genes encoding various other accessory proteins were also identified, including Eag chaperones, TagJ, and an unknown protein with COG5435 domain and similarity to an Eag chaperone (SciW) which may function like EagT6 to load the Tse6-like protein onto the VgrG spike (Fig. 4a).

Fig. 4.

Fig. 4.

Gene organization of representative T6SS clusters. In all clusters shown, genes encoding components of the T6SS are colour coded as follows: membrane complex (red), baseplate complex (blue), tail complex (yellow) and unknown genes (grey). Flanking tRNAs, if present, are coloured black. Details on all effectors predicted by SecReT6 for all isolates investigated are presented in Table S7. (a) E. bugandensis E104107 possesses a complete T6SSi3 cluster containing all 13 core components required for secretion, along with multiple putative regulators, effectors, and other accessory genes. Known effectors and immunity protein genes are coloured green, and novel effector candidates are coloured cyan. Additional details on the functional analysis of this cluster are given in Table S5. (b) Example of a complete T6SSi2-i cluster from E. cloacae EFN743. (c) Example of a complete T6SSi2-ii cluster from E. cloacae POL9. (d) Example of a complete T6SSi2-iii cluster from E. bugandensis E105227. (e) Incomplete T6SSi2-iii cluster in E. bugandensis E104107, which also lacks putative effectors. PSTP and PSTK denote genes encoding predicted phosphatase and kinase proteins, respectively. This figure was made using the clinker command within cblaster, and score values indicate cluster similarity. The locus tags corresponding to each gene in this figure are shown in Table S5.

Many E. bugandensis and E. cloacae strains possessed additional clusters belonging to subtype i2. We identified three i2 clusters across the 31 genomes based on genomic location by visual inspection; these were termed T6SSi2-i, T6SSi2-ii and T6SSi2-iii. The number of i2 clusters was variable across the genomes analysed; strains possessed between zero and two i2 clusters and evidence of deletion was observed. Therefore, we referred to T6SSi2-i, T6SSi2-ii and T6SSi2-iii as ‘secondary’ clusters, as they were less conserved in the E. bugandensis and E. cloacae strains analysed. All E. bugandensis strains harboured one T6SSi2 cluster, and half of them contained a second T6SSi2 cluster. E. cloacae strains displayed more variability; most (68.4%) possessed one i2 cluster and only one strain (5.3%) possessed two i2 clusters.

T6SSi2-i, T6SSi2-ii and T6SSi2-iii clusters were conserved within the same genomic location in all strains possessing these clusters. Therefore, genomic location was used to differentiate these clusters. T6SSi2-iii clusters were flanked upstream by a gene encoding an EAL domain-containing protein and a downstream fadJ gene. Twelve T6SSi2-iii clusters were identified across the 31 genomes, and all non-degraded clusters contained 13 core components required for a functional T6SS (Fig. S3). Unlike T6SSi3, which contained structural genes in a block, structural genes in T6SSi2-iii clusters were scattered throughout. However, T6SSi2-iii displayed a conserved gene layout made up of six structural genes in all 12 clusters, including tssBCKLDH (Figs 4d and S3). A conserved gene encoding an OmpA domain protein was located between tssL and tssD; it had predicted structural similarity to TssM and the closest amino acid sequence identity to TssL from Acidovorax citrulli AAC00-1. The other TssL protein is a recognizable short form of TssL – also called SciP – which lacks an OmpA extension. The number of unknown genes and vgrG genes varied between clusters. Nineteen T6SSi2-ii clusters were identified; they displayed variation in gene layout and organization, differing in orientation, size, and the number of vgrG and tssH genes (Fig. S4). For example, E. cloacae POL9 possessed one vgrG gene while E. bugandensis FDAARGOS_1496 possessed four vgrG genes. T6SSi2-ii clusters were conserved in the same genomic location across all strains that possessed this cluster and were flanked by an upstream OppA peptide ABC transporter substrate-binding protein. The upstream layout of conserved structural genes resembled that of T6SSi2-iii, and clusters displayed a conserved layout of tssBCKLDH (Figs 4c and S4). Like T6SSi2-iii, T6SSi2-ii also possessed a conserved gene encoding an OmpA-like protein located between tssL and tssD (Fig. 4c). Only two T6SSi2-i clusters were identified in two E. cloacae strains within our dataset, revealing that this cluster is not widespread across E. cloacae and E. bugandensis strains. Both T6SSi2-i clusters were identified by genomic location and were found in the same genomic region, flanked by an upstream FAD-NAD(P) binding protein (Fig. S5). One T6SSi2-i was complete and contained all 13 T6SS core components; however, the other T6SSi2-i cluster was incomplete and lacked several core structural genes required for secretion. Similar to T6SSi2-ii and T6SSi2-iii, the complete T6SSi2-i cluster displayed a gene layout consisting of six structural genes, including tssBCKLDH (Figs 4b and S5). T6SSi2-i also possessed a conserved gene encoding an OmpA-like protein located between tssL and tssD.

Genomic layout of the T6SS in the E. bugandensis E104107 model strain reveals two T6SS clusters and multiple auxiliary modules

E. bugandensis E104107 is a clinical isolate in our lab collection that was obtained from a respiratory sample. It is highly resistant to polymyxins [76] and virulent in the Galleria mellonella infection model (data not shown), as also reported for the E. bugandensis EB-247 type strain [54]. For these reasons, we used E104107 as a model E. bugandensis strain to explore the biology of infection by this species; in this study, we focused on this strain for further analysis of the T6SS. E104107 harbours two T6SS clusters, a complete primary T6SSi3 and an incomplete secondary T6SSi2-iii cluster that displayed evidence of deletion (Fig. 4a, e).

The E. bugandensis E104107 incomplete T6SSi2-iii cluster harboured seven (tssABCDHKL) of the 13 core T6SS gene components. All components of the tail complex were present; however, genes encoding the baseplate (TssEFG and VgrG) and membrane (TssJM) complexes were absent, suggesting T6SSi2-iii is insufficient for secretion. This cluster was determined as a T6SSi2-iii based on genomic location in comparison to other strains included in the dataset. It is unknown whether this T6SSi2-iii cluster is non-functional or may utilize T6SSi3 structural components under certain conditions to form a functional T6SS. T6SSi2-iii E104107 possesses only structural genes, and no unknown or predicted effectors were identified; its gene organization was identical to the first six genes of T6SSi2-iii from other E. bugandensis and E. cloacae strains (including tssBCKLD). The adjacent tssH gene is truncated, and its product was 99.0 % identical to the first 402 aa of T6SSi2-iii TssH from E. bugandensis E105227, another strain from our dataset with a complete T6SSi2-iii cluster. Additionally, a tRNA was located immediately downstream of T6SSi2-iii, adjacent to tssA. tRNAs are often found adjacent to pathogenicity islands and may serve as sites for foreign DNA insertion via horizontal gene transfer, and also as sites for homologous recombination between genomes [77]. Together, these findings indicate a deletion event may have occurred within T6SSi2-iii E104107, resulting in the loss of several structural and unknown-function genes.

E104107 lacked a T6SSi2-ii cluster; however, tssBC remnant genes were identified in the same genomic location as T6SSi2-ii in other strains. There were no putative effectors or other T6SS-associated genes surrounding tssBC E104107 , and TssBE104107 had 98.2 % amino acid sequence similarity to T6SSi2-ii TssB of E. bugandensis type strain EB-247, an example of an E. bugandensis strain with a complete T6SSi2-ii cluster. Additionally, 151 of 153 aa of TssCE104107 were identical to the beginning of TssCEB-247 in T6SSi2-ii, indicating the presence of a truncated T6SSi2-ii tssC gene in the E104107 genome. Together, these findings indicate a deletion event occurred in tssC that eliminated almost every gene of T6SSi2-ii in E. bugandensis E104107. No T6SS-assocated genes were located at the same genomic location as T6SSi2-i in other strains, demonstrating the absence of this cluster in E. bugandensis E104107.

T6SSi2-ii is functional in E. cloacae ATCC 13047, playing a role in biofilm formation, adherence to epithelial cells and intestinal colonization [40]. However, it only contains 12 of 13 core components, lacking hcp. Deletion of T6SSi2-ii tssH ATCC13047 resulted in reduced adherence to HeLa cell monolayers [40] and reduced mouse intestinal colonization at 3 days post-infection. Moreover, a double deletion mutant of T6SSi3 tssH ATCC13047 and T6SSi2-ii tssH ATCC13047 resulted in significantly reduced colonization compared to wild-type E. cloacae ATCC 13047 [40]. T6SSi3 ATCC13047 was also implicated in bacterial competition; deletion of T6SSi3 tssH ATCC13047 abolished the competitiveness of E. cloacae ATCC 13047 during inter-bacterial competition, while deletion of T6SSi2-ii tssH ATCC13047 had no significant effect. Compared to E. cloacae ATCC 13047, there were differences in gene organization of the variable downstream VgrG region of both T6SSi3 clusters.

T6SSi3 E104107 encodes all 13 core structural components required for secretion (TssA-M) with the same gene layout as all T6SSi3 clusters from the other strains in our dataset. In addition, T6SSi3 E104107 carries genes encoding numerous putative effectors, immunity proteins, regulators and chaperones (Table S5). Moreover, E. bugandensis E104107 contains nine hcp genes scattered across the genome. One hcp gene was found in T6SSi3 (hcp6) and T6SSi2-iii (hcp8). The remaining seven lone hcp genes were scattered across the genome, often in association with an array of putative effector genes, representing auxiliary modules.

A T6SSi3 vgrG gene encodes a novel putative metallopeptidase domain

Two VgrG proteins were encoded within E. bugandensis E104107 T6SSi3. The predicted structure of VgrG2 (861 aa) corresponds to a canonical VgrG head, with an extended spike portion at the beginning of the C-terminal region. The C-terminal region has an extension positioned at the side of the spike portion (Fig. 5). This extension, joined to the main canonical VgrG2 structure by a flexible domain, contains eight predicted α-helices and three anti-parallel β-sheets. The C-terminal extension exhibits a gluzincin metallopeptidase domain at amino acid positions 689–757. The gluzincin metallopeptidase domain was identified on the C-terminal extensions of two E. bugandensis strains and no E. cloacae strains within our curated dataset. The gluzincin family are a group of thermolysin-like peptidases, including several zinc-dependent metallopeptidases with a diverse variety of functions. A similar metallopeptidase domain is present on the C-terminal extension of VgrG2b of Pseudomonas aeruginosa PAO1, which elicits toxicity in the periplasm of prey bacteria by causing membrane blebbing and lysis [78]. VgrG2b can also promote bacterial internalization in epithelial cells by interacting with microtubule components [26]. However, the molecular mechanisms behind these phenotypes remain unclear. Structural and sequence comparisons of PAO1 and E104107 C-terminal extensions demonstrated that both are distinct proteins with different structures (Fig. 5c–f). PAO1 VgrG2b had six α-helices and three anti-parallel β-sheets, whereas E104107 VgrG2 possessed eight α-helices and three anti-parallel β-sheets. The full PAO1 and E104107 putative effector domain alone, as well as the recognizable metallopeptidase domain alone, did not complementarily align, underlining the distinctness of these proteins (Fig. 5e). PAO1 VgrG2b has a zinc-binding motif, HEXXH, as part of the active site, which was also present in the predicted gluzincin peptidase domain of the E104107 VgrG2 C-terminal extension. Structural alignment of this binding domain and surrounding amino acids revealed a similar arrangement of two α-helices and three β-sheets surrounding the zinc-binding domain within each metallopeptidase fold (Fig. 5f).

Fig. 5.

Fig. 5.

Predicted structure of the VgrG2 monomer and comparison of VgrG2 effector domain with P. aeruginosa PAO1 VgrG2b effector domain. (a) VgrG2 structure was confidently predicted using Colabfold (Alphafold 2.0 and MMseqs2) and was coloured by pLDDT confidence score. (b) VgrG2-predicted structure displays a head and spike portion with a putative effector domain (highlighted by grey circle). The VgrG2 putative effector domain exhibits a recognizable gluzincin-family metallopeptidase domain (yellow) and possesses a total of eight α-helices and three anti-parallel β-sheets to form a compact structure on the side of the VgrG spike. (c) The putative effector domain of E. bugandensis E104107 (red) was predicted using Colabfold (Alphafold 2.0 and MMseqs2) and (d) the crystal structure of P. aeruginosa PAO1 VgrG2b effector domain (PDB ID: 6H56) (blue). (e) E104107 (red) and PAO1 (blue) effector domain structures could not be confidently aligned using PyMoL, demonstrating that they are distinct proteins. (f) Modelling of the putative E104107 effector domain (red, with yellow indicating the conserved HEXXH motif) and PAO1 effector domain active site (blue, with orange indicating the conserved HEXXH motif) reveals similar structures.

VgrG3 had an identical structure to the first ~645 aa of VgrG2, representing the head and spike portions (Fig. 6d). Unlike VgrG2, VgrG3 lacked predicted effector domains on the C-terminal extension. Therefore, VgrG3 is unlikely to be an evolved effector, and the C-terminal extension may function to sharpen the VgrG spike for more efficient puncturing and effector delivery. VgrG3 was identified in two E. bugandensis strains; however, VgrG homologues lacking predicated effector domains on their C-terminal regions were also identified. Furthermore, 17 E. cloacae strains possessed homologues with 93–94 % amino acid sequence identity to VgrG3. The VgrG homologues differed by a recognizable baseplate-subunit-and-tail-lysozyme domain at amino acid positions 493–564.

Fig. 6.

Fig. 6.

Comparison of three VgrG structures located in the E. bugandensis E104107 genome. (a–c) Structures of three VgrG proteins located in the E. bugandensis E104107 genome were confidently modelled using Colabfold (Alphafold 2.0 and MMseqs2) and are coloured by pLDDT score. (d) Structural alignment using PyMoL reveals that the head and spike portion of VgrG2 and VgrG3 are identical, and VgrG2 possesses an additional, putative, C-terminal effector domain located on the side of the spike. (e) Structural alignment reveals that VgrG1 and VgrG3 possess a highly similar head portion while the spike portions are different. The VgrG1 spike portion extends further than VgrG3 to elongate the structure.

Two putative anti-bacterial PAAR proteins are located within T6SSi3

We searched the E. bugandensis E104107 genome for the presence of PAAR-domain containing genes. All identified PAAR domain-containing genes possessed additional motifs which may represent toxins. No genes encoding exclusively PAAR domains were identified. T6SSi3 encodes two PAAR proteins, RhsA and a Tse6-like protein. PAAR (Proline–Alanine–Alanine–aRginine) proteins assemble onto the blunt end of the VgrG spike as a sharp, conical extension to facilitate penetration of target cell membranes [79]. The PAAR domain may also act as a chaperone and often exhibits C-terminal extensions which encode effectors [52, 79–81]. RhsA and RhsB proteins are crucial for bacterial killing and efficient Hcp secretion in E. cloacae ATCC 13047 [52]. Bacteria can secrete Rhs effectors to antagonize both bacteria and eukaryotic cells; however, not all are secreted in a T6SS-dependent manner [82–85]. Rhs proteins contain Rhs/YD-peptide repeats which form a β-cage structure to encapsulate the C-terminal toxin domain and may prevent autointoxication [52]. E. cloacae ATCC 13047 requires Rhs PAAR motifs to stabilize the VgrG trimer and the β-cage for efficient T6SSi3 assembly [52]. These domains ensure cargo effectors are loaded onto VgrG prior to T6SS assembly. The function of the RhsA C-terminal toxin domain is unknown. However, autoproteolysis releases the C-terminal toxin domain from RhsA and this cleavage is required for anti-bacterial activity [52]. The RhsB C-terminal domain contains a Tox-GHH DNase domain separated from the Rhs/YD core by a DPxGL motif [52]. Similarly, this motif separates the Rhs/YD core and C-terminal toxin domain of RhsA. RhsB is absent in the E. bugandensis E104107 genome, but RhsA was identified in T6SSi3 and exhibited 87.3 % amino acid sequence identity to ATCC 13047 RhsA. The PAAR and Rhs/YD regions of E104107 and ATCC 13047 RhsA had high sequence identity, but the C-terminal domains were different. E104107 contained a recognizable domain of unknown function (DUF3990). The function of this domain, which is also found in T6SS-associated Rhs proteins from other bacteria [82], is unknown. In ATCC 13047, RhsA can intoxicate bacteria but its function in E. bugandensis remains to be established. The rhsA gene was conserved across the 31 genomes and was found in all E. bugandensis and 12 (63.2 %) E. cloacae strains analysed, while rhsB was highly conserved in E. cloacae and was identified in 18 strains (94.7%); however, rhsB was not conserved in E. bugandensis as it was only identified in one strain.

E104107 T6SSi3 also contains a Tse6-like PAAR protein. Tse6 is a NAD(P)+ glycohydrolase effector in P. aeruginosa that degrades NAD+ and NADP+, both essential dinucleotides [86]. An EagT6 chaperone protects the hydrophobic transmembrane regions of Tse6 from aggregation and degradation prior to loading onto VgrG [81]. Tse6 is believed to be delivered by the T6SS into the periplasm of target cells where it spontaneously embeds into the membrane and allows the toxin domain to translocate across the inner membrane into the cytoplasm to exert its toxicity [81]. Tse6 also requires the essential housekeeping protein, translation elongation factor Tu (EF-Tu), for entry into target cells; it is unknown how EF-Tu facilitates entry [81, 86]. E104107 Tse6-like protein had 36.9 % amino acid sequence identity to Tse6. The transmembrane regions of P. aeruginosa Tse6 did not align with the transmembrane regions of E. bugandensis E104107 Tse6-like protein, but the Ntox46 toxin domain of the E104107 Tse6-like protein aligned identically with the Ntox46 domain of Tse6 from P. aeruginosa (Fig. 7d–e). E104107 Tse6-like protein also possessed 66.5 % amino acid sequence identity to Tre1 from Serratia proteamaculans . Although the toxin domains of Tre1 and E104107 Tse6-like protein were distinct, the N-terminal PAAR and transmembrane helices of the Tse6-like protein displayed high structural similarity to Tre1 (Fig. 7f–g). Tre1 is an ADP-ribosyltransferase that blocks cell division by modifying the essential bacterial tubulin-like protein, FtsZ [87]. Tse6-like protein was less conserved across the 31 genomes and was identified in two E. bugandensis and two E. cloacae strains; these findings highlight the diversity of effectors encoded in E. cloacae and E. bugandensis strains and support the hypothesis that Tse6-like protein may have evolved from a fusion event between two effectors. E104107 T6SSi3 contains both Tsi6 and Tri1, the immunity proteins for Tse6 and Tre1, respectively. Tri1 protects from self-intoxication by two modes, including active site occlusion and removing enzymatic modification of proteins by its corresponding effector, Tre1 [87]. T6SSi3 possesses an adjacent additional predicted ADP-ribosyl glycohydrolase immunity protein. Both immunity proteins contain recognizable ADP-ribosyl glycohydrolase domains and have significant sequence similarity to Tri1 from S. proteamaculans . E104107 Tri1 displayed 75 % amino acid sequence identity to S. proteamaculans Tri1, and the adjacent additional ADP-ribosyl glycohydrolase displayed 50 % sequence identity. No corresponding effectors were identified for these immunity proteins, but it is unknown whether effectors are located elsewhere in the genome. Alternatively, rather than protecting against self-intoxication by effectors, these lone immunity proteins may have been acquired by E. bugandensis E104107 to increase immunity against attacking cells.

Fig. 7.

Fig. 7.

Comparison of E. bugandensis E104107 Tse6-like protein structure with Tse6 from P. aeruginosa and Tre1 from S. proteamaculans, and comparison of E. bugandensis E104107 and enterohaemorrhagic Escherichia coli (EHEC) KatN structures. Structures of (a) Tre1 from S. proteamaculans , (b) Tse6-like protein from E. bugandensis E104107 and (c) Tse6 from P. aeruginosa were confidently modelled using Colabfold (Alphafold 2.0 and MMseqs2) and coloured by pLDDT score. Complete predicted structures of Tse6 and Tre1 were used since only the toxin domains have been crystallized. (d) Alignment of E104107 Tse6-like protein toxin domain (green) and P. aeruginosa Tse6 toxin domain (orange) structures display high structural similarity. (e) Alignment of E104107 Tse6-like protein PAAR+ transmembrane regions (green) and P. aeruginosa Tse6 PAAR+ transmembrane regions (orange) display lower structural similarity. (f) Structures of the E104107 Tse6-like protein toxin domain (green) and Tre1-toxin domain (blue) were aligned and exhibit different structures. (g) Alignment of the E104107 Tse6-like protein PAAR+ transmembrane regions (green) and Tre1 PAAR+ transmembrane regions (blue) display high structural similarity. (h) The structure of E. bugandensis KatN and (i) EHEC KatN were confidently predicted using Colabfold (Alphafold 2.0 and MMseqs2) and are coloured by pLDDT score. (j) Structural alignment using PyMoL reveals that E104107 KatN (red) and EHEC KatN (blue) are highly similar.

T6SSi3 harbours a Tae4-like anti-bacterial effector

Tae4 is the only effector encoded within the structural region of E104107 T6SSi3. Tae4 (Type VI Amidase Effector 4) is an anti-bacterial amidase effector with a N1pC/P60 domain [41]. It acts as a dl-endopeptidase that hydrolyses the peptide bond between γ-d-glutamic and meso-diaminopimelic acid [41]. The tae4 gene is highly conserved across the 31 genomes of our dataset; all E. bugandensis and 14 E. cloacae (73.7%) strains carry a tae4 gene. The immunity protein, Tai4 (Type VI Amidase Immunity 4), protects against self-intoxication by forming a dimer with Tae4. The Tae4/Tai4 interface comprises a heterotetramer of two Tae4 molecules and a Tai4 dimer in solution [41]. Inhibition requires a Tai4 dimer as one subunit is important for binding Tae4 while the other blocks Tae4 activity [41]. E104107 Tae4 displayed 96.3 % amino acid sequence identity to E. cloacae ATCC 13047 Tae4, while E104107 Tai4 had 79.5 % sequence identity to ATCC 13047 Tai4.

Additional putative T6SS effectors are present outside T6SS clusters

A third vgrG gene (vgrG1) was identified outside of the T6SS clusters and was not associated with any other T6SS genes. The head portion of VgrG1 was structurally identical to that of VgrG2 and VgrG3 (Fig. 6e). However, there were differences in the spike portion; the VgrG1 spike was longer and consisted of additional anti-parallel β-sheets and α-helices. Additionally, VgrG1 displayed a recognizable DUF2345 domain on its C-terminal extension. VgrG1 was identified in two E. bugandensis strains within our curated dataset; however, VgrG homologues also possessing a DUF2345 domain were identified in E. bugandensis and E. cloacae strains. E104107 VgrG1 was associated with an adjacent putative effector displaying DUF3289 and M23 peptidase domains. M23 family metallopeptidases are zinc-dependent and degrade peptidoglycan [88]. The function of DUF3289 is unknown but has been identified in T6SS genes, including PAAR-related proteins [89]. A small, unknown ORF was located immediately downstream of the putative peptidase effector and may represent the corresponding immunity protein. This M23 family peptidase has not been explored and is not present in the SecReT6 database of known effectors, suggesting it is a novel effector. The M23 peptidase gene was less conserved across the 31 genomes and was only identified in two E. bugandensis strains, highlighting the diversity of encoded effectors in E. bugandensis and E. cloacae .

Another gene, also not associated with T6SS clusters, was identified in the E. bugandensis E104107 genome, and encoded a manganese-containing catalase with 89 % amino acid sequence identity to KatN from enterohemorrhagic Escherichia coli (EHEC). The predicted structures of EHEC and E104107 KatN were almost identical (Fig. 7h–j). Both KatN structures displayed 10 α-helices and two β-sheets with short regions at the C-termini that could not be accurately predicted by alphafold. All 31 strains possessed katN, revealing that it appears highly conserved across E. bugandensis and E. cloacae strains.

Three lone PAAR domain-carrying genes were identified across the E. bugandensis E104107 genome. These genes encode N-terminal PAAR domains and C-terminal extensions harbouring S-type pyocin domains, and were termed ppp1, ppp2 and ppp3 (PAAR Pyocin-S domain-containing Protein). Pyocins are colicin-like, protease-sensitive bacteriocins produced by Pseudomonas species; their killing activity is mediated by DNase, lipase, tRNase and channel-forming activities [90]. All proteins were similar in size (521, 565 and 579 aa) and possessed a similarly sized S-type pyocin domain (132–142 aa) at approximately the same amino acid positions (~298–442). Amino acid sequence analysis revealed that Ppp1 and Ppp2 were similar and displayed 66.7 % sequence identity, while Ppp3 displayed only 39.7 % sequence identity to Ppp1 and 32 % sequence identity to Ppp2. Ppp2 carries an additional ‘cytotoxic’ domain (Pfam ID: PF09000) which causes nucleolytic breaks in 16S rRNA, and is found in Escherichia coli ribonuclease colicin E3 [91]. These proteins were absent in the SecReT6 database of known effectors. S-type pyocin domains have been identified on the C-terminal extensions of Enterobacteriaceae hcp genes and were found to elicit anti-bacterial effects [92]. Therefore, Ppp1–3 may represent novel anti-bacterial effectors. Twenty pyocin-S domain-containing proteins were identified in E. bugandensis strains, and 24 were identified in E. cloacae strains from our curated dataset.

Discussion

We have characterized in silico the distribution and diversity of T6SS gene clusters in isolates from E. cloacae and E. bugandensis , both of which are clinically relevant species of the genus Enterobacter . From the initial dataset of 90 complete genomes identified as ‘ E. cloacae ’ and ‘ E. bugandensis ’, we demonstrated that only 31 were taxonomically assigned to these species. This highlights the importance of verifying Enterobacter strain taxonomy before carrying out comparative studies given the current complexity of Enterobacter taxonomy. The genus Enterobacter consists of multiple species and the entries in NCBI do not reflect the updated taxonomic classifications [93]. The pipeline outlined in this study can be extended to include more species of the E. cloacae complex and other T6SS-weilding bacteria.

The E. cloacae and E. bugandensis strains in our curated dataset encode up to three T6SS clusters, of which T6SSi3 is present and complete in most strains. The organization of T6SSi3 structural genes was also conserved across all strains; however, strains exhibited diversity in the array of encoded effectors and unknown genes. Many strains harboured one or two additional clusters belonging to subtype i2. We identified three i2 clusters across the 31 strains (termed T6SSi2-i, T6SSi2-ii and T6SSi2-iii), and these were conserved in genomic location but displayed evidence of deletion and diversity in gene organization. T6SS cluster diversity may have resulted from the arms-race between bacteria to outcompete one another in their environmental niche. Furthermore, gain and loss of clusters may be related to fitness costs, balancing the high energy cost associated with T6SS maintenance, resulting in deletion events, and the specific pressures in the niches where these isolates evolved.

Detailed analysis of our model isolate, E. bugandensis E104107, revealed nine hcp genes. While T6SSi3 E104107 and T6SSi2-iii E104107 clusters contained one hcp gene each, the other seven hcp genes were scattered across the genome. They were often associated with an array of putative effector genes, representing predicted auxiliary modules. These observations indicate a potential for additional effectors being exchanged in nature among Enterobacter strains, or strains from other species, which may be significant for niche adaption. Similar auxiliary modules were also present in the other 30 genomes included in our study; work is ongoing to characterize the distribution and diversity of effectors within these modules. Furthermore, we identified several previously described and unknown putative effectors in E. bugandensis E104107, including two VgrG, three pyocin-S domain-containing PAAR proteins (Ppp1–3), Tse6-like protein, KatN, Tae4, RhsA and peptidase proteins. Pyocins may have been acquired by Enterobacter species by horizontal gene transfer and fused with PAAR proteins to produce new anti-bacterial effectors. While the T6SS may deliver effectors to the cytoplasm or periplasm of target cells [81, 94], it is also possible that the pyocin domain may aid in delivering effectors from the periplasm to the cytoplasm of target cells. In EHEC, KatN expression was induced by the stress regulators, RpoS and OxyR, contributing to virulence by promoting intracellular survival within macrophages [95]. These findings suggest KatN could have a similar function in E. bugandensis . VgrG1 has a DUF2345 domain, but the function of this domain in Enterobacter species is unknown. In Escherichia coli , DUF2345 was shown to stabilize the interaction between VgrG and the phospholipase effector, Tle1 [20]. However, a single amino acid change in Acinetobacter baumannii VgrGi DUF2345 was observed to inhibit T6SS function, possibly by eliminating the energy cost associated with producing functional T6SS since it appears to be unnecessary for A. baumannii virulence [96]. Additionally, Klebsiella pneumoniae VgrG4 possesses a C-terminal DUF2345 which can intoxicate bacteria and yeast via induction of reactive oxygen species [97] and can serve as an anti-eukaryotic effector promoting fragmentation of the mitochondrial network and activation of innate immune receptor NLRX1 [98].

In summary, our results highlight new anti-eukaryotic and anti-bacterial effector candidates which may facilitate adaption and dominance of Enterobacter species within their environmental niches. Notably, the identification of effector candidates, such as KatN and VgrG1 with a potential role in pathogenesis, may provide new avenues to better understand the infection biology of Enterobacter species.

Supplementary Data

Supplementary material 1

Funding information

A.J.G.A. was supported by a Postgraduate Scholarship from the Department of Economy, Northern Ireland. This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BB/T005807/1 to M.A.V. and G.L.C., and BB/S006281/1 to M.A.V.).

Conflicts of interest

The authors declare no conflict of interest.

Ethical statement

Not applicable for this study.

Footnotes

Abbreviations: EHEC, enterohaemorrhagic Escherichia coli; Hcp, haemolysin-coregulated protein; PAAR, proline–alanine–alanine–arginine; Rhs, rearrangement hotspot protein; Tae4, type VI amidase effector 4; Tai4, type VI amidase immunity 4; Tde, type VI DNase and RNase effector; Tle, type VI lipase effector; Tre, type VI ADP-ribosyltransferase effector; Tse, type VI secretion system effector; T6SS, type VI secretion system; TYGS, type (strain) genome server; VgrG, valine–glycine repeat protein G.

All supporting data, code and protocols have been provided within the article or through supplementary data files. Five supplementary figures and seven supplementary tables are available with the online version of this article.

References

  • 1.Jean-Pierre F, Vyas A, Hampton TH, Henson MA, O’Toole GA, et al. One versus many: polymicrobial communities and the cystic fibrosis airway. mBio. 2021;12 doi: 10.1128/mBio.00006-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.García-Bayona L, Comstock LE. Bacterial antagonism in host-associated microbial communities. Science. 2018;361 doi: 10.1126/science.aat2456. [DOI] [PubMed] [Google Scholar]
  • 3.Hibbing ME, Fuqua C, Parsek MR, Peterson SB. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol. 2010;8:15–25. doi: 10.1038/nrmicro2259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Whitney JC, Peterson SB, Kim J, Pazos M, Verster AJ, et al. A broadly distributed toxin family mediates contact-dependent antagonism between gram-positive bacteria. Elife. 2017;6:e26938. doi: 10.7554/eLife.26938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Aoki SK, Pamma R, Hernday AD, Bickham JE, Braaten BA, et al. Contact-dependent inhibition of growth in Escherichia coli . Science. 2005;309:1245–1248. doi: 10.1126/science.1115109. [DOI] [PubMed] [Google Scholar]
  • 6.Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubès R, et al. Colicin biology. Microbiol Mol Biol Rev. 2007;71:158–229. doi: 10.1128/MMBR.00036-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, et al. Type VI secretion delivers bacteriolytic effectors to target cells. Nature. 2011;475:343–347. doi: 10.1038/nature10244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hespanhol JT, Sanchez-Limache DE, Nicastro GG, Mead L, Llontop EE, et al. Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases. eLife. 2022;11 doi: 10.7554/eLife.82437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Le NH, Pinedo V, Lopez J, Cava F, Feldman MF. Killing of Gram-negative and Gram-positive bacteria by a bifunctional cell wall-targeting T6SS effector. Proc Natl Acad Sci USA. 2021;118 doi: 10.1073/pnas.2106555118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Park YJ, Lacourse KD, Cambillau C, DiMaio F, Mougous JD, et al. Structure of the type VI secretion system TssK–TssF–TssG baseplate subcomplex revealed by cryo-electron microscopy. Nat Commun. 2018;9 doi: 10.1038/s41467-018-07796-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Durand E, Nguyen VS, Zoued A, Logger L, Péhau-Arnaudet G, et al. Biogenesis and structure of a type VI secretion membrane core complex. Nature. 2015;523:555–560. doi: 10.1038/nature14667. [DOI] [PubMed] [Google Scholar]
  • 12.Zoued A, Brunet YR, Durand E, Aschtgen M-S, Logger L, et al. Architecture and assembly of the Type VI secretion system. Biochim Biophys Acta. 2014;1843:1664–1673. doi: 10.1016/j.bbamcr.2014.03.018. [DOI] [PubMed] [Google Scholar]
  • 13.Douzi B, Spinelli S, Blangy S, Roussel A, Durand E, et al. Crystal structure and self-interaction of the type VI secretion tail-tube protein from enteroaggregative Escherichia coli . PLoS One. 2014;9:e86918. doi: 10.1371/journal.pone.0086918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Stietz MS, Liang X, Li H, Zhang X, Dong TG. TssA-TssM-TagA interaction modulates type VI secretion system sheath-tube assembly in Vibrio cholerae . Nat Commun. 2020;11:5065. doi: 10.1038/s41467-020-18807-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dix SR, Owen HJ, Sun R, Ahmad A, Shastri S, et al. Structural insights into the function of type VI secretion system TssA subunits. Nat Commun. 2018;9 doi: 10.1038/s41467-018-07247-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ. Type VI secretion requires a dynamic contractile phage tail-like structure. Nature. 2012;483:182–186. doi: 10.1038/nature10846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhou Y, Tao J, Yu H, Ni J, Zeng L, et al. Hcp family proteins secreted via the type VI secretion system coordinately regulate Escherichia coli K1 interaction with human brain microvascular endothelial cells. Infect Immun. 2012;80:1243–1251. doi: 10.1128/IAI.05994-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Pissaridou P, Allsopp LP, Wettstadt S, Howard SA, Mavridou DAI, et al. The Pseudomonas aeruginosa T6SS-VgrG1b spike is topped by a PAAR protein eliciting DNA damage to bacterial competitors. Proc Natl Acad Sci U S A. 2018;115:12519–12524. doi: 10.1073/pnas.1814181115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Suarez G, Sierra JC, Erova TE, Sha J, Horneman AJ, et al. A type VI secretion system effector protein, VgrG1, from Aeromonas hydrophila that induces host cell toxicity by ADP ribosylation of actin. J Bacteriol. 2010;192:155–168. doi: 10.1128/JB.01260-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Flaugnatti N, Le TTH, Canaan S, Aschtgen M-S, Nguyen VS, et al. A phospholipase A1 antibacterial Type VI secretion effector interacts directly with the C-terminal domain of the VgrG spike protein for delivery. Mol Microbiol. 2016;99:1099–1118. doi: 10.1111/mmi.13292. [DOI] [PubMed] [Google Scholar]
  • 21.Ma S, Dong Y, Wang N, Liu J, Lu C, et al. Identification of a new effector-immunity pair of Aeromonas hydrophila type VI secretion system. Vet Res. 2020;51 doi: 10.1186/s13567-020-00794-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ. Identification of T6SS-dependent effector and immunity proteins by Tn-seq in Vibrio cholerae . Proc Natl Acad Sci U S A. 2013;110:2623–2628. doi: 10.1073/pnas.1222783110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lin J, Zhang W, Cheng J, Yang X, Zhu K, et al. A Pseudomonas T6SS effector recruits PQS-containing outer membrane vesicles for iron acquisition. Nat Commun. 2017;8:14888. doi: 10.1038/ncomms14888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jiang F, Wang X, Wang B, Chen L, Zhao Z, et al. The Pseudomonas aeruginosa type VI secretion PGAP1-like effector induces host autophagy by activating endoplasmic reticulum stress. Cell Reports. 2016;16:1502–1509. doi: 10.1016/j.celrep.2016.07.012. [DOI] [PubMed] [Google Scholar]
  • 25.Russell AB, LeRoux M, Hathazi K, Agnello DM, Ishikawa T, et al. Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors. Nature. 2013;496:508–512. doi: 10.1038/nature12074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Sana TG, Baumann C, Merdes A, Soscia C, Rattei T, et al. Internalization of Pseudomonas aeruginosa strain PAO1 into epithelial cells is promoted by interaction of a T6SS effector with the microtubule network. mBio. 2015;6:e00712. doi: 10.1128/mBio.00712-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Jiang F, Waterfield NR, Yang J, Yang G, Jin Q. A Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cells. Cell Host Microbe. 2014;15:600–610. doi: 10.1016/j.chom.2014.04.010. [DOI] [PubMed] [Google Scholar]
  • 28.Jana B, Keppel K, Fridman CM, Bosis E, Salomon D. Multiple T6SSs, mobile auxiliary modules, and effectors revealed in a systematic analysis of the Vibrio parahaemolyticus pan-genome. mSystems. 2022;7:e0072322. doi: 10.1128/msystems.00723-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Morgado S, Vicente AC. Diversity and distribution of type VI secretion system gene clusters in bacterial plasmids. Sci Rep. 2022;12:8249. doi: 10.1038/s41598-022-12382-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Crisan CV, Chande AT, Williams K, Raghuram V, Rishishwar L, et al. Analysis of Vibrio cholerae genomes identifies new type VI secretion system gene clusters. Genome Biol. 2019;20:163. doi: 10.1186/s13059-019-1765-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Han Y, Wang T, Chen G, Pu Q, Liu Q, et al. A Pseudomonas aeruginosa type VI secretion system regulated by CueR facilitates copper acquisition. PLOS Pathog. 2019;15:e1008198. doi: 10.1371/journal.ppat.1008198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Aubert DF, Xu H, Yang J, Shi X, Gao W, et al. A Burkholderia type VI effector deamidates rho GTPases to activate the pyrin inflammasome and trigger inflammation. Cell Host Microbe. 2016;19:664–674. doi: 10.1016/j.chom.2016.04.004. [DOI] [PubMed] [Google Scholar]
  • 33.Yang Y, Pan D, Tang Y, Li J, Zhu K, et al. H3-T6SS of Pseudomonas aeruginosa PA14 contributes to environmental adaptation via secretion of a biofilm-promoting effector. Stress Biol. 2022;2:55. doi: 10.1007/s44154-022-00078-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Trunk K, Peltier J, Liu Y-C, Dill BD, Walker L, et al. The type VI secretion system deploys antifungal effectors against microbial competitors. Nat Microbiol. 2018;3:920–931. doi: 10.1038/s41564-018-0191-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wenren LM, Sullivan NL, Cardarelli L, Septer AN, Gibbs KA. Two independent pathways for self-recognition in Proteus mirabilis are linked by type VI-dependent export. mBio. 2013;4:e00374-13. doi: 10.1128/mBio.00374-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Eshraghi A, Kim J, Walls AC, Ledvina HE, Miller CN, et al. Secreted effectors encoded within and outside of the Francisella pathogenicity island promote intramacrophage growth. Cell Host Microbe. 2016;20:573–583. doi: 10.1016/j.chom.2016.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci USA. 2007;104:15508–15513. doi: 10.1073/pnas.0706532104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Zong B, Zhang Y, Wang X, Liu M, Zhang T, et al. Characterization of multiple type-VI secretion system (T6SS) VgrG proteins in the pathogenicity and antibacterial activity of porcine extra-intestinal pathogenic Escherichia coli . Virulence. 2019;10:118–132. doi: 10.1080/21505594.2019.1573491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ringel PD, Hu D, Basler M. The role of type VI secretion system effectors in target cell lysis and subsequent horizontal gene transfer. Cell Reports. 2017;21:3927–3940. doi: 10.1016/j.celrep.2017.12.020. [DOI] [PubMed] [Google Scholar]
  • 40.Soria-Bustos J, Ares MA, Gómez-Aldapa CA, González-Y-Merchand JA, Girón JA, et al. Two type VI secretion systems of Enterobacter cloacae are required for bacterial competition, cell adherence, and intestinal colonization. Front Microbiol. 2020;11:560488. doi: 10.3389/fmicb.2020.560488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zhang H, Zhang H, Gao Z-Q, Wang W-J, Liu G-F, et al. Structure of the type VI effector-immunity complex (Tae4-Tai4) provides novel insights into the inhibition mechanism of the effector by its immunity protein. J Biol Chem. 2013;288:5928–5939. doi: 10.1074/jbc.M112.434357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lery LMS, Frangeul L, Tomas A, Passet V, Almeida AS, et al. Comparative analysis of Klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor. BMC Biol. 2014;12:41. doi: 10.1186/1741-7007-12-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Carruthers MD, Nicholson PA, Tracy EN, Munson RS, Cascales E. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS One. 2013;8:e59388. doi: 10.1371/journal.pone.0059388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wang J, Zhou Z, He F, Ruan Z, Jiang Y, et al. The role of the type VI secretion system vgrG gene in the virulence and antimicrobial resistance of Acinetobacter baumannii ATCC 19606. PLoS One. 2018;13:e0192288. doi: 10.1371/journal.pone.0192288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wu W, Feng Y, Zong Z. Precise species identification for Enterobacter: a genome sequence-based study with reporting of two novel species, Enterobacter quasiroggenkampii sp. nov. and Enterobacter quasimori sp. nov. mSystems. 2020;5:e00527-20. doi: 10.1128/mSystems.00527-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zong Z, Feng Y, McNally A. Carbapenem and colistin resistance in Enterobacter: determinants and clones. Trends Microbiol. 2021;29:473–476. doi: 10.1016/j.tim.2020.12.009. [DOI] [PubMed] [Google Scholar]
  • 47.Parte AC, Sardà Carbasse J, Meier-Kolthoff JP, Reimer LC, Göker M. List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol. 2020;70:5607–5612. doi: 10.1099/ijsem.0.004332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Girlich D, Ouzani S, Emeraud C, Gauthier L, Bonnin RA, et al. Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort study. Lancet Microbe. 2021;2:e536–e544. doi: 10.1016/S2666-5247(21)00098-7. [DOI] [PubMed] [Google Scholar]
  • 49.Maheshwari N, Shefler A. Enterobacter cloacae: an “ICU bug” causing community acquired necrotizing meningo-encephalitis Eur J Pediatr 2009168503–505. 10.1007/s00431-008-0790-2 [DOI] [PubMed] [Google Scholar]
  • 50.Ferry A, Plaisant F, Ginevra C, Dumont Y, Grando J, et al. Enterobacter cloacae colonisation and infection in a neonatal intensive care unit: retrospective investigation of preventive measures implemented after a multiclonal outbreak BMC Infect Dis 202020682. 10.1186/s12879-020-05406-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Hernandez-Alonso E, Bourgeois-Nicolaos N, Lepainteur M, Derouin V, Barreault S, et al. Contaminated incubators: source of a multispecies Enterobacter outbreak of neonatal sepsis. Microbiol Spectr. 2022;10:e00964–22. doi: 10.1128/spectrum.00964-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Donato SL, Beck CM, Garza-Sánchez F, Jensen SJ, Ruhe ZC, et al. The β-encapsulation cage of rearrangement hotspot (Rhs) effectors is required for type VI secretion. Proc Natl Acad Sci USA. 2020;117:33540–33548. doi: 10.1073/pnas.1919350117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Doijad S, Imirzalioglu C, Yao Y, Pati NB, Falgenhauer L, et al. Enterobacter bugandensis sp. nov., isolated from neonatal blood. Int J Syst Evol Microbiol. 2016;66:968–974. doi: 10.1099/ijsem.0.000821. [DOI] [PubMed] [Google Scholar]
  • 54.Pati NB, Doijad SP, Schultze T, Mannala GK, Yao Y, et al. Enterobacter bugandensis: a novel enterobacterial species associated with severe clinical infection. Sci Rep. 2018;8:5392. doi: 10.1038/s41598-018-23069-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Hervas JA, Ballesteros F, Alomar A, Gil J, Benedi VJ, et al. Increase of Enterobacter in neonatal sepsis: a twenty-two-year study. Pediatr Infect Dis J. 2001;20:134–140. doi: 10.1097/00006454-200102000-00003. [DOI] [PubMed] [Google Scholar]
  • 56.Dalben M, Varkulja G, Basso M, Krebs VLJ, Gibelli MA, et al. Investigation of an outbreak of Enterobacter cloacae in a neonatal unit and review of the literature. J Hosp Infect. 2008;70:7–14. doi: 10.1016/j.jhin.2008.05.003. [DOI] [PubMed] [Google Scholar]
  • 57.Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance Future Microbiol 20127887–902. 10.2217/fmb.12.61 [DOI] [PubMed] [Google Scholar]
  • 58.Meier-Kolthoff JP, Göker M. TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy. Nat Commun. 2019;10 doi: 10.1038/s41467-019-10210-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Zhang J, Guan J, Wang M, Li G, Djordjevic M, et al. SecReT6 update: a comprehensive resource of bacterial type VI secretion systems. Sci China Life Sci. 2023;66:626–634. doi: 10.1007/s11427-022-2172-x. [DOI] [PubMed] [Google Scholar]
  • 60.Li J, Yao Y, Xu HH, Hao L, Deng Z, et al. SecReT6: a web-based resource for type VI secretion systems found in bacteria. Environ Microbiol. 2015;17:2196–2202. doi: 10.1111/1462-2920.12794. [DOI] [PubMed] [Google Scholar]
  • 61.Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res. 2021;49:W293–W296. doi: 10.1093/nar/gkab301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Gilchrist CLM, Booth TJ, van Wersch B, van Grieken L, Medema MH, et al. cblaster: a remote search tool for rapid identification and visualization of homologous gene clusters. Bioinform Adv. 2021;1:vbab016. doi: 10.1093/bioadv/vbab016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Gilchrist CLM, Chooi Y-H, Robinson P. clinker & clustermap.js: automatic generation of gene cluster comparison figures. Bioinformatics. 2021;37:2473–2475. doi: 10.1093/bioinformatics/btab007. [DOI] [PubMed] [Google Scholar]
  • 64.Wang J, Yang B, Leier A, Marquez-Lago TT, Hayashida M, et al. Bastion6: a bioinformatics approach for accurate prediction of type VI secreted effectors. Bioinformatics. 2018;34:2546–2555. doi: 10.1093/bioinformatics/bty155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Söding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 2005;33:W244–8. doi: 10.1093/nar/gki408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845–858. doi: 10.1038/nprot.2015.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Holm L. Dali server: structural unification of protein families. Nucleic Acids Res. 2022;50:W210–W215. doi: 10.1093/nar/gkac387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.McGinnis S, Madden TL. BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Res. 2004;32:W20–5. doi: 10.1093/nar/gkh435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Marchler-Bauer A, Bryant SH. CD-Search: protein domain annotations on the fly. Nucleic Acids Res. 2004;32:W327–31. doi: 10.1093/nar/gkh454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Teufel F, Almagro Armenteros JJ, Johansen AR, Gíslason MH, Pihl SI, et al. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol. 2022;40:1023–1025. doi: 10.1038/s41587-021-01156-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Bendtsen JD, Kiemer L, Fausbøll A, Brunak S. Non-classical protein secretion in bacteria. BMC Microbiol. 2005;5 doi: 10.1186/1471-2180-5-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Mirdita M, Schütze K, Moriwaki Y, Heo L, Ovchinnikov S, et al. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19:679–682. doi: 10.1038/s41592-022-01488-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Russell AB, Wexler AG, Harding BN, Whitney JC, Bohn AJ, et al. A type VI secretion-related pathway in bacteroidetes mediates interbacterial antagonism. Cell Host Microbe. 2014;16:227–236. doi: 10.1016/j.chom.2014.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Barret M, Egan F, O’Gara F. Distribution and diversity of bacterial secretion systems across metagenomic datasets. Environ Microbiol Rep. 2013;5:117–126. doi: 10.1111/j.1758-2229.2012.00394.x. [DOI] [PubMed] [Google Scholar]
  • 75.Barret M, Egan F, Fargier E, Morrissey JP, O’Gara F. Genomic analysis of the type VI secretion systems in Pseudomonas spp.: novel clusters and putative effectors uncovered. Microbiology. 2011;157:1726–1739. doi: 10.1099/mic.0.048645-0. [DOI] [PubMed] [Google Scholar]
  • 76.Mushtaq S, Reynolds R, Gilmore MC, Esho O, Adkin R, et al. Inherent colistin resistance in genogroups of the Enterobacter cloacae complex: epidemiological, genetic and biochemical analysis from the BSAC Resistance Surveillance Programme. J Antimicrob Chemother. 2020;75:2452–2461. doi: 10.1093/jac/dkaa201. [DOI] [PubMed] [Google Scholar]
  • 77.Schmidt H, Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev. 2004;17:14–56. doi: 10.1128/CMR.17.1.14-56.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Wood TE, Howard SA, Förster A, Nolan LM, Manoli E, et al. The Pseudomonas aeruginosa T6SS delivers a periplasmic toxin that disrupts bacterial cell morphology. Cell Reports. 2019;29:187–201. doi: 10.1016/j.celrep.2019.08.094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Shneider MM, Buth SA, Ho BT, Basler M, Mekalanos JJ, et al. PAAR-repeat proteins sharpen and diversify the type VI secretion system spike. Nature. 2013;500:350–353. doi: 10.1038/nature12453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Uchida K, Leiman PG, Arisaka F, Kanamaru S. Structure and properties of the C-terminal β-helical domain of VgrG protein from Escherichia coli O157. J Biochem. 2014;155:173–182. doi: 10.1093/jb/mvt109. [DOI] [PubMed] [Google Scholar]
  • 81.Quentin D, Ahmad S, Shanthamoorthy P, Mougous JD, Whitney JC, et al. Mechanism of loading and translocation of type VI secretion system effector Tse6. Nat Microbiol. 2018;3:1142–1152. doi: 10.1038/s41564-018-0238-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Alcoforado Diniz J, Coulthurst SJ, Christie PJ. Intraspecies competition in Serratia marcescens is mediated by type VI-secreted Rhs effectors and a conserved effector-associated accessory protein. J Bacteriol. 2015;197:2350–2360. doi: 10.1128/JB.00199-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Günther P, Quentin D, Ahmad S, Sachar K, Gatsogiannis C, et al. Structure of a bacterial Rhs effector exported by the type VI secretion system. PLoS Pathog. 2022;18:e1010182. doi: 10.1371/journal.ppat.1010182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Kung VL, Khare S, Stehlik C, Bacon EM, Hughes AJ, et al. An rhs gene of Pseudomonas aeruginosa encodes a virulence protein that activates the inflammasome. Proc Natl Acad Sci U S A. 2012;109:1275–1280. doi: 10.1073/pnas.1109285109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Lu W, Tan J, Lu H, Wang G, Dong W, et al. Function of Rhs proteins in porcine extraintestinal pathogenic Escherichia coli PCN033. J Microbiol. 2021;59:854–860. doi: 10.1007/s12275-021-1189-2. [DOI] [PubMed] [Google Scholar]
  • 86.Whitney JC, Quentin D, Sawai S, LeRoux M, Harding BN, et al. An interbacterial NAD(P)+ glycohydrolase toxin requires elongation factor tu for delivery to target cells. Cell. 2015;163:607–619. doi: 10.1016/j.cell.2015.09.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Ting S-Y, Bosch DE, Mangiameli SM, Radey MC, Huang S, et al. Bifunctional immunity proteins protect bacteria against FtsZ-targeting ADP-ribosylating toxins. Cell. 2018;175:1380–1392. doi: 10.1016/j.cell.2018.09.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Razew A, Schwarz JN, Mitkowski P, Sabala I, Kaus-Drobek M. One fold, many functions—M23 family of peptidoglycan hydrolases. Front Microbiol. 2022;13 doi: 10.3389/fmicb.2022.1036964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Zhang Z, Liu Y, Zhang P, Wang J, Li D, et al. PAAR proteins are versatile clips that enrich the antimicrobial weapon arsenals of prokaryotes. mSystems. 2021;6:e00953–21. doi: 10.1128/mSystems.00953-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Dingemans J, Ghequire MGK, Craggs M, De Mot R, Cornelis P. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate. Microbiologyopen. 2016;5:413–423. doi: 10.1002/mbo3.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Carr S, Walker D, James R, Kleanthous C, Hemmings AM. Inhibition of a ribosome-inactivating ribonuclease: the crystal structure of the cytotoxic domain of colicin E3 in complex with its immunity protein. Structure. 2000;8:949–960. doi: 10.1016/S0969-2126(00)00186-6. [DOI] [PubMed] [Google Scholar]
  • 92.Ma J, Pan Z, Huang J, Sun M, Lu C, et al. The Hcp proteins fused with diverse extended-toxin domains represent a novel pattern of antibacterial effectors in type VI secretion systems. Virulence. 2017;8:1189–1202. doi: 10.1080/21505594.2017.1279374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Doijad SP, Gisch N, Frantz R, Kumbhar BV, Falgenhauer J, et al. Resolving colistin resistance and heteroresistance in Enterobacter species. Nat Commun. 2023;14:140. doi: 10.1038/s41467-022-35717-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Vettiger A, Basler M. Type VI secretion system substrates are transferred and reused among sister cells. Cell. 2016;167:99–110. doi: 10.1016/j.cell.2016.08.023. [DOI] [PubMed] [Google Scholar]
  • 95.Wan B, Zhang Q, Ni J, Li S, Wen D, et al. Type VI secretion system contributes to Enterohemorrhagic Escherichia coli virulence by secreting catalase against host reactive oxygen species (ROS) PLoS Pathog. 2017;13:e1006246. doi: 10.1371/journal.ppat.1006246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Lopez J, Ly PM, Feldman MF. The tip of the VgrG spike is essential to functional type VI secretion system assembly in Acinetobacter baumannii . mBio. 2020;11:e02761-19. doi: 10.1128/mBio.02761-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Storey D, McNally A, Åstrand M, sa-Pessoa Graca Santos J, Rodriguez-Escudero I, et al. Klebsiella pneumoniae type VI secretion system-mediated microbial competition is PhoPQ controlled and reactive oxygen species dependent. PLoS Pathog. 2020;16:e1007969. doi: 10.1371/journal.ppat.1007969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Sá-Pessoa J, López-Montesino S, Przybyszewska K, Rodríguez-Escudero I, Marshall H, et al. A trans-kingdom T6SS effector induces the fragmentation of the mitochondrial network and activates innate immune receptor NLRX1 to promote infection. Nat Commun. 2023;14:871. doi: 10.1038/s41467-023-36629-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material 1

Articles from Microbial Genomics are provided here courtesy of Microbiology Society

RESOURCES